MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION-Reference-Cited by-同舟云学术

MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION

Published:2000-06 Issue:11 Volume:69 Page:2405-2409
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Ojo Akinlolu O.,Meier-Kriesche Herwig-Ulf,Hanson Julie A.,Leichtman Alan B.,Cibrik Diane,Magee John C.,Wolfe Robert A.,Agodoa Lawrence Y.,Kaplan Bruce

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. Chronic renal transplant loss

2. Chronic allograft nephropathy: An update

3. Rethinking Chronic Allograft Nephropathy

4. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Transplant Tolerance with Biomaterials;Advanced Healthcare Materials;2024-07-03

2. Efficacy and Safety of Mycophenolate Mofetil In De Novo Renal Transplantation in a Retrospective Cohort of Transplant Recipients in Colombia—Esmitren Study;Transplantation Proceedings;2024-03

3. Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery;Advanced Drug Delivery Reviews;2024-03

4. Preventing kidney transplant failure by screening for antibodies against human leucocyte antigens followed by optimised immunosuppression: OuTSMART RCT;Efficacy and Mechanism Evaluation;2023-09

5. Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial;eClinicalMedicine;2023-02